Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventors Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Technologies
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • Core activities
          • Stories and insights
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Technologies
        • Go back
        • Overview
        • Innovation against cancer
        • Assistive robotics
        • Space technologies
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
          • Go back
          • Overview
          • Publications
        • Research universities and public research organisations
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2024
          • Go back
          • Overview
          • Executive summary
          • Driver 1 – People
          • Driver 2 – Technologies
          • Driver 3 – High-quality, timely products and services
          • Driver 4 – Partnerships
          • Driver 5 – Financial Sustainability
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 0960/15 (Radiotherapeutic treatment plan adaptation / Philips) 22-12-2021
Facebook X Linkedin Email

T 0960/15 (Radiotherapeutic treatment plan adaptation / Philips) 22-12-2021

European Case Law Identifier
ECLI:EP:BA:2021:T096015.20211222
Date of decision
22 December 2021
Case number
T 0960/15
Petition for review of
-
Application number
05779771.4
IPC class
A61N 5/00
G06K 9/00
Language of proceedings
EN
Distribution
DISTRIBUTED TO BOARD CHAIRMEN (C)

Download and more information:

Decision in EN 467.31 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

RADIOTHERAPEUTIC TREATMENT PLAN ADAPTATION

Applicant name
Koninklijke Philips N.V.
Opponent name
RaySearch Laboratories AB
Board
3.4.01
Headnote
-
Relevant legal provisions
European Patent Convention Art 56
European Patent Convention Art 84
European Patent Convention Art 100(a)
European Patent Convention Art 107
European Patent Convention Art 114(2)
Rules of procedure of the Boards of Appeal Art 12(2)
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(2)
Rules of procedure of the Boards of Appeal Art 24(1)
Rules of procedure of the Boards of Appeal Art 25(1)
Keywords

Positive discretionary decision - legal basis for review (yes)

Positive discretionary decision - set aside (no)

Inventive step (main request, auxiliary requests I, IV')

Inventive step - (no); (auxiliary request II')

Inventive step - effect not made credible within the whole scope of claim

Claims - clarity

Claims - (auxiliary requests I, I', II, II', III, III', IV) (no)

Amendment to appeal case (auxiliary requests I',I'', II'', II''', III'')

Amendment to appeal case - suitability of amendment to resolve issues raised (no)

Catchword
The Boards of Appeal may review discretionary decisions. There are, however, limits on the extent of review that reflect the discretion accorded to the deciding body. In the present case, the Opposition Division decided to consider document D8 and the review of this decision is a primary object of the appeal proceedings (Article 12(2) RPBA 2020) - see Reasons 1 - 9.
Cited decisions
G 0007/93
T 0677/08
T 1883/12
T 1209/05
Citing decisions
T 2035/16
T 2742/18
T 0934/19
T 1206/19
T 1193/21
T 1311/21
T 2036/22
T 2194/22

I. An opposition was filed against the entirety of European Patent EP-B-1 778 353. Among the documents submitted in support were:

D1: Lu W. et al,"Automatic re-contouring regions of interest based on deformable registration and surface reconstruction", AAPM 46th Annual Meeting, Scientific Abstracts and Sessions, Medical Physics, Vol. 31(6), June 2004, 1845-1846;

D2: US-A-2002/0122530.

II. In its interlocutory decision, the Opposition Division decided that, account being taken of the amendments made by the patent proprietor during the opposition proceedings according to an eighth auxiliary request, the patent and the invention to which it related met the requirements of the EPC.

III. The Opposition Division announced its interlocutory decision at oral proceedings. As is common practise, it also announced decisions on a number of issues as the debate progressed. It is not necessary to reproduce them here, except to note that, after the announcement of a decision to the effect that claims 1 and 4 of auxiliary request II lacked clarity, the proprietor sought to file clarifying amendments to that request, and to others. The Opposition Division declined to admit further requests. (See section 6 of the minutes, and, in particular, the correction issued to paragraph 6.5.)

IV. Both the patent proprietor and the opponent appealed.

V. With its notice of appeal, the opponent requested that the decision be set aside and the patent revoked.

VI. With its statement of grounds, the proprietor requested that the decision be set aside and that the opposition be rejected, i.e. the patent be maintained as granted (main request); and filed claim sets for auxiliary requests I to IX and II', III', V' and VII'.

VII. The main request and auxiliary requests I, II, III, V, VII and VIII were the same as the identically labelled requests before the Opposition Division. The remainder were new on appeal.

VIII. The proprietor also requested the setting aside of the Opposition Division's decision to admit document D8:

D8: Weiguo Lu: "Motion detection and correction for image guided radiation therapy", Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medical Physics) at the University of Wisconsin - Madison - 2001.

IX. In its reply to the opponent's appeal, the proprietor filed further claim sets for auxiliary requests VIII', VIII'' and IX, the latter replacing auxiliary request IX as filed with the statement of grounds.

X. Both parties requested oral proceedings.

XI. The Board summoned to oral proceedings and issued its preliminary opinion according to Article 15(1) RPBA.

XII. With its response to the Board's preliminary opinion, the proprietor filed claim sets for further auxiliary requests I', I'', II'', II''', III'', IV', V'', V''', V'''', VI', VIIIa, VIII'a, VIII''a, and IX'.

XIII. As confirmed at the start of oral proceedings, the ranking of the 30 requests was: the main request followed by auxiliary request I, I', I'', II, II', II'', II''', III, III', III'', IV, IV', V, V', V'', V''', V'''', VI, VI', VII, VII', VIII, VIIIa, VIII', VIII'a, VIII'', VIII''a, IX and IX', in that order.

XIV. During oral proceedings, the proprietor withdrew auxiliary requests V to IX' (cf. the above ranking).

XV. Hence, the proprietor's requests at the end of the oral proceedings were that the decision under appeal be set aside and that the opposition be rejected, i.e. the patent be maintained as granted (main request); or that the patent be maintained according to one of auxiliary requests I, I', I'', II, II', II'', II''', III, III', III'', IV or IV'.

XVI. The opponent's request at the end of oral proceedings was that the decision under appeal be set aside and the patent revoked.

XVII. Independent claim 1 of the main request (patent as granted) reads:

A radiation therapy system for radiation therapy of a subject in accordance with a radiation treatment plan computed based on information representative of a tissue to be irradiated, the radiation therapy system comprising a means (40, 70, 72) for adjusting radiation treatment parameters of a previously selected radiation treatment plan based on treatment images to produce an adjusted treatment plan, wherein the previously selected treatment plan parameters are optimized from irradiated tissue contours generated from a planning image and the means (40, 70, 72) for adjusting comprises:

an images registration processor (70) for registering the treatment image with the planning image using an elastic deformation technique, wherein the planning image is deformed;

a contour update processor (72) for adjusting the irradiated tissue contours by deforming the contours in accordance with the deformation of the planning image, to conform to the treatment image; and

a treatment plan parameter optimizing processor (40) for re-optimizing the treatment parameters from the adjusted contours.

XVIII. Independent claim 4 of the main request reads:

A method of updating a radiation therapy plan comprising:

acquiring a treatment image;

registering the treatment image with a corresponding planning image using an elastic deformation technique, wherein the planning image is deformed; and

updating radiation therapy planning contours of tissue to be irradiated by deforming the contours in accordance with the deformation of the planning image.

XIX. In auxiliary request I, as compared to the main request, claim 4 is amended by the addition of the features

... [therapy plan,] wherein the radiation therapy plan comprises treatment parameters which have previously been optimized from irradiated tissue contours generated from a planning image, the method [comprising]

... [deformation of the planning image], and

re-optimizing the treatment parameters from the updated radiation therapy planning contours.

XX. In auxiliary request I', the first step of claim 4 is further defined, as compared to the main request, to read

... [therapy plan comprising]

providing the radiation therapy plan to be updated, wherein the radiation therapy plan comprises treatment parameters which have previously been optimized from irradiated tissue contours generated from a planning image;

[acquiring ... ]

(emphasis of further definition as compared to auxiliary request I by the Board).

XXI. The claims of auxiliary request I'' are claims 1 to 3 of the patent.

XXII. In auxiliary request II, independent claim 1 is amended, as compared to claim 1 of the main request, to define the treatment images and the planning images as

... treatment images having a lower resolution ...

and

... planning images having a higher resolution ...

(emphasis by the Board).

Claim 4 is amended similarly.

XXIII. The claims of auxiliary request II' correspond those of auxiliary request I, with, however, the following addition in claim 1 (and a similar amendment to claim 4):

... wherein the treatment images have a lower resolution than the planning image ...

XXIV. The claims of auxiliary request II'' correspond to the claims of auxiliary request I', with, however, the following addition in independent claim 1 and a similar amendment to claim 4:

... wherein the treatment images have a lower resolution than the planning image ....

XXV. The claims of auxiliary request II''' are claims 1 to 3 of auxiliary request II'.

XXVI. Auxiliary request III corresponds to auxiliary request II, but amended by the following additions to claims 1 and 4 respectively:

1. ...[adjusted contours,] wherein the treatment image is not used to extract information on radiation attenuation or tissue density.

4. ... [planning image]; and

re-optimizing treatment parameters of the radiation therapy plan from the updated contours, wherein the treatment image is not used to extract information on radiation attenuation or tissue density.

XXVII. Claim 1 of auxiliary request III' corresponds to that of the main request, with, however, the additions:

... [planning image], wherein treatment images have a lower resolution than the corresponding planning image [and] wherein [the means (40, 70, 72)] ...

[adjusted contours], wherein the treatment image is not used to extract information on radiation attenuation or tissue density.

Claim 4 of auxiliary request III' is amended similarly and also by the further addition:

... re-optimizing treatment parameters of the radiation therapy plan from the updated contours.

XXVIII. In claims 1 and 4 of auxiliary request III'', as compared to auxiliary request III',

... wherein the treatment image is not used to extract information on radiation attenuation or tissue density

is replaced by:

... wherein the treatment image is not used to construct the contours, but, by using the deformation obtained from the registration of the treatment image with the planning image, the treatment image is only used to adjust the size, shape, orientation, position or another spatial aspect of the contour ...

XXIX. Claims 1 and 4 of auxiliary request IV corresponds to those of the main request, with, however, the following additions:

1. ... [adjusted contours], wherein the optimization process is omitted, if the registration process indicates stability of the irradiated region since a last treatment session.

4. ... [planning image]; and

re-optimizing treatment parameters of the radiation therapy plan from the updated contours wherein the optimization process is omitted, if the registration process indicates stability of the irradiated region since a last treatment session.

XXX. In claims 1 and 4 of auxiliary request IV', as compared to auxiliary request IV, the term "optimization process" is replaced with "re-optimization process".

XXXI. The parties' arguments, in so far as they are relevant to the decision, are reproduced below, in the Reasons. XXXII. In addition to D1, D2 and D8, this decision also refers to Maintz, which is mentioned in paragraph [0030] of the patent as describing Some suitable registration techniques: Maintz & Viergever, "A survey of medical image registration", Medical Image Analysis, vol. 2(1), 1998, 1-36 |

Admission of document D8

1. In the run-up to the oral proceedings before the Opposition Division, the opponent introduced D8 as a new basis for attacking the patented invention's novelty and inventive step. During the oral proceedings, the opponent sought, and the proprietor disputed, the admission of D8. In that regard, the parties appear to have debated, mainly, the relevance and the size of the document (minutes, points 5.7 to 5.9; appealed decision, point 6.1). The Opposition Division considered both these aspects and admitted D8 into the proceedings (appealed decision, points 6.1.1 and 6.2; minutes, point 5.10). The Opposition Division concluded that claim 4 of the first auxiliary request lacked novelty over D8 (appealed decision, point 7; minutes, points 5.11 and 5.12).

2. In the statement of grounds of appeal, while disagreeing with the Opposition Division's exercise of discretion primarily with regard to the document's relevance, the proprietor challenged the decision to admit it into the proceedings (page 6, point III, 1.1). The Board interprets this as a request that the Opposition Division's discretionary decision to admit D8 be set aside.

3. The admission of D8 lay within the Opposition Division's discretion under Article 114(2) EPC. When exercising this discretion, it enjoyed a certain degree of freedom; and the Board should normally not interfere in such a discretionary decision. In particular, it should not do so simply because, under the same circumstances, the Board itself would have decided differently. The Board should only overrule such a decision, if it concludes that the department that took it applied the wrong principles, took no account of the right principles, or exercised its discretion in an unreasonable way, thus exceeding the proper limits of its discretion (see, for example, G 7/93 Late amendments OJ EPC 1994 775, reason 2.6; T 677/08, Payment Processing/SAP, reason 4.3; T 1883/12, No-spill drinking cup/Philips, reason 3.1.2; Case Law of the Boards of Appeal of the European Patent Office, 9th edition, IV.C.4.5.2, V.A.3.5.1 and V.A.3.5.4; and with particular reference to the review of a discretionary decision to admit a document into the proceedings, T 1209/05, Refrigerator oil/NIPPON MITSUBISHI, reason 2).

4. There is, therefore, long-established jurisprudence setting out the Boards' powers to review discretionary decisions, and the limits on those powers that reflect the decisions' discretionary nature. This extends to a discretionary decision to admit a submission, such as D8.

5. Furthermore, since the proprietor was adversely affected by the admission of D8, which document was later found to anticipate the first auxiliary request, the proprietor was within its rights to direct its case to that aspect, or part, of the appealed decision (Article 107, first sentence, EPC).

6. Article 12(2) RPBA 2020 introduced a general definition of the nature and scope of the appeal proceedings in accordance with the established case law (see EPO OJ Supplement 2/2020, explanatory remark, page 33/65). Under this provision (which is applicable, see Article 25(1) RPBA 2020), D8 itself and the parties' cases in respect of its admission into the proceedings belong to "the requests, facts, objections, arguments and evidence on which the decision under appeal was based".

7. Hence, the Board is competent to review the Opposition Division's decision to admit D8, and such a review belongs to the primary object of these appeal proceedings.

8. It thus lay within the Opposition Division's discretion to disregard D8, or not. When reviewing the decision not to disregard it, the Board cannot identify any error in the principles applied, or not applied, by the Opposition Division, or anything unreasonable about it. On the contrary, the Opposition Division demonstrated the relevance it saw in D8, when considering it novelty-destroying in respect of the first auxiliary request. Furthermore, the Opposition Division apparently only needed to read some parts of the extensive D8 to verify its relevance (appealed decision, point 6.1.1).

9. Accordingly, the Board does not set aside the discretionary decision to admit D8, and will take account of this document.

Main request

10. The claims of the main request are those of the patent as granted. The Opposition Division held that claim 4 lacked novelty over document D1.

11. In writing and during oral proceedings in appeal proceedings, the proprietor argued that D1 did not disclose the following features of independent claims 1 and 4:

(a) In D1, the reference image was not used as a planning image.

(b) In D1, no deformation of the planning image was suggested and, consequently, no updating of contours in accordance with the deformation of the planning image.

(c) D1 only suggested a deformable registration technique, but not an elastic deformation.

12. With regard to feature (a), D1 discloses an "Automatic Re-contouring of Regions of Interest" (D1, Title), wherein contours of regions of interest in a reference image are used in order automatically to re-contour them in test images. D1 does not explicitly state that the "reference image" and the "test image" are used to generate or adapt a treatment plan, but deals with the method by which contours in the reference image can be used automatically to re-contour the test images. The starting point of D1, however, is that automatic re-contouring in treatment images could be used routinely to modify planning. Hence, the skilled person would easily understand that the disclosed re-contouring is actually used to modify treatment plans. In order to modify a treatment plan by re-contouring regions of interest, it is necessary that an initial plan exists and the only image that could be used for this initial plan is the reference image. Consequently, the reference image of D1 is the planning image of independent claims 1 and 4.

13. With regard to feature (b), the proprietor argued that in D1, the regions in the test image are re-contoured and, hence, the test image should be understood as the basis on which the treatment plan is modified. In contrast, in claims 1 and 4, the planning image (which corresponds to the reference image in D1) and its contours were deformed and these deformed, adjusted contours were used as the basis for an adapted treatment plan.

14. Firstly, it should be mentioned that, in both claims 1 and 4, the deforming of the planning image is defined as part of registering the planning image and the treatment image. In the patent specification (B1-document, column 6, lines 13 to 16) it is described that Preferably, the planning images are deformed to register with the treatment images, but deforming the treatment images to register with the planning images is also contemplated. There is no indication in the patent specification that the registering step is more complicated using one transformation direction than the other. Hence, after deriving a deformation of an image in one direction (for instance, deforming the treatment image onto the planning image by adding respective displacement vectors), there is no hint at any difficulty in inverting the process, so that the transformation can work in the other direction (for instance, deforming the planning image onto the treatment image by subtracting the respective displacement vectors). It is also contemplated, in the patent specification, (B1, column 6, lines 17 to 21) Once the images are registered, a contours update processor 72 deforms or otherwise updates the contours representing the malignant tissue and the one or more organs at risk in accordance with the deformation ..., i.e. only using the "deformation" without any reference to the image that is actually deformed. Hence, the direction of transformation does not involve an inventive step.

15. Secondly, for adapting the treatment plan, the original contours of the planning image have to be deformed in order to match the contours of the (actual) treatment image. Hence, the direction of transformation of the contours was straightforward and the choice does not involve an inventive step.

16. The proprietor further argued that, while deforming the planning image and not the treatment image, it would be possible to use treatment images of lower resolution while at the same time keeping a high-resolution planning image as the basis for adapting the treatment plan.

17. However, none of the independent claims define the resolution of the planning and treatment images. Hence, the alleged advantage is not obtained over the whole breadth of the claim, and, consequently, can not support an inventive step.

18. With regard to feature (c), D1 only mentions "deformation" not "elastic deformation". According to the Maintz, "elastic" means "mapping lines onto curves" (Maintz lines 4 to 5 of section 5.1.), as distinct from rigid, affine, and projective transformations. In the human body, tissue moves and changes shape, as was common general knowledge. The person skilled in the art would have chosen an elastic deformation in order to follow the movement of tissues more precisely than is possible with rigid, affine or projective transformations.

19. Hence, the subject-matters of claims 1 and 4 lack an inventive step in view of document D1 and the skilled person's common general knowledge (Articles 100(a) and 56 EPC).

Auxiliary request I

20. In auxiliary request I, claim 1 is identical to claim 1 of the main request. It lacks inventive step for the reasons given above.

Auxiliary requests I' and I''

21. Auxiliary requests I' and I'' were filed in response to the Board's preliminary opinion and after notification of the summons to oral proceedings. In both, claim 1 is identical to that of the main request, and the lack of inventive step applies. Hence, neither request is admitted into the appeal proceedings, as neither is suited to overcoming objections already raised (Article 13(2) RPBA 2020, under which the criteria of Article 13(1) RPBA 2020 may be applied).

Auxiliary request II

22. In auxiliary request II, amendments were made, inter alia, to the effect that treatment images have a lower resolution and the planning image a higher. The Opposition Division did not allow this request (decision, "Second auxiliary request", section 8.2), since the relative terms "lower" and "higher" were considered unclear, because an unambiguous reference was missing. In the statement of grounds (in particular, in section 2.1.2), the proprietor argued that the person skilled in the art would construe the patent with "a mind willing to understand", and understand that "the treatment images have a lower resolution than the planning image".

23. As already pointed out in the Board's preliminary opinion (section 5.2), claims should be formulated in as clear a way as possible. As stated by the Opposition Division, the proprietor's formulation is open to interpretations different from the clear wording "the treatment images have a lower resolution than the planning image", which was readily available. The adoption of ambiguous wording means that claims 1 and 4 lack clarity (Article 84 EPC).

Auxiliary request II'

24. Auxiliary request II' addresses the clarity of lower and higher resolution in auxiliary request II.

25. This request is admitted into the appeal proceedings, as a straightforward solution to the clarity issue in auxiliary request II, although it could have been filed before the Opposition Division.

26. After the Opposition Division had announced its decision regarding this point of clarity, the proprietor sought to file amended versions of claims 1 and 4, so that they would explicitly state that the treatment images had lower resolution than the planning image (minutes section 6.5, as amended by letter of 4 May 2015).

27. The Opposition Division did not give reasons for not admitting a request with the amendment under discussion, beyond noting that The opponent objects to filing a further new auxiliary request by pointing to the number of pending requests and the late stage of the procedure. (minutes, section 6.5 both before and after correction).

28. Auxiliary request II' was filed with the statement of grounds, so that in appeal proceedings no "late stage of the proceedings" is present, that might prevent the opponent (or the Board) dealing thoroughly with the request. The Board takes the view that the amendment rather simplifies the appeal than complicates it.

29. Hence, auxiliary request II' is admitted into the appeal proceedings (Article 12(4) RPBA 2007). This does not mean the Opposition Division was wrong to decline to admit it. The circumstances are different.

30. In order to discuss inventive step of claims 1 and 4 of auxiliary request II', it is appropriate to start from document D8, which, besides the features disclosed in document D1, also discloses an elastic deformation (see feature (c), above, and D8: Abstract, section: "Deformable registration", page iv) and a planning image (see feature (a) above, D8: glossary, page xxvii). As D8 discloses that the target image or the planning image might be deformed (D8: page 243), feature (b) above is at least obvious from document D8.

31. The proprietor saw a further difference in that D8 focused on another way of using deformable image registration, i.e. keeping a "basis" image for (for example) calculating a dose that is given to a particular voxel of this "basis" image and deforming an actual image taken during a fraction of the therapy in order to "sum up" the doses in the "basis" image. It might then be envisaged to use this "basis" image to optimize further radiation therapy steps. In order to apply a deformable registration for that purpose, there would be no need for updating contours for deriving an updated treatment plan.

32. However, as pointed out by the Opposition Division (decision, reasons, section 7.2.1), in D8 the use of deformable registration is not restricted to dose calculation. Its use for updating regions of interest (comprising its "contours") between a planning and a fraction image is disclosed, for instance, in the paragraph on page 267 and in Figure 8-14, and the use of deformable image registration "to setup the treatment beam" (which is comprised by "re-optimizing treatment parameters", as currently claimed) is envisaged on page 174, lines 3 to 6.

33. Another argument provided by the proprietor seems to rely on the moment in time when the treatment image is taken (cf. statement of grounds, section 1.2.3), i.e. that previous treatment images (of previous fractions) are used in D8, instead of using the current treatment image. There is, however, nothing in the claims 1 and 4 that specifies whether a "current" or a "previous" treatment image is used.

34. Consequently, the only feature that might possibly establish an inventive step of claims 1 and 4 compared to document D8 is the added feature: wherein the treatment images have a lower resolution than the planning image.

35. Following the well-established problem-solution approach, the technical effect of this feature has to be found.

36. The proprietor argued that the technical effect of this feature was - as in the patent specification - that imaging systems might be used that were less complicated, less time-consuming, and which might expose the patient to less radiation.

37. In this regard, the patent specification describes (paragraph [0034], for instance:

This enables the second imaging system 60 to be a low-cost, low resolution imager that rapidly acquires the one or more treatment images. Moreover, the second imaging system 60 can employ a non-radiation based imaging modality such as ultrasound or magnetic resonance, since the treatment images are not used to extract information on radiation attenuation or tissue density for calibrating the treatment plan.

38. However, neither claim 1 nor claim 4 actually defines a particular imaging system that would ensure corresponding technical effects. Neither different imaging modalities, nor different exposure times, nor any algorithm that would reduce the time for the patient is defined. Only the resolutions of the planning and the treatment images are compared. For instance, it is not excluded that the low-resolution treatment image is obtained by reducing the resolution of an originally high-resolution treatment image, thereby failing to achieve any of the alleged technical effects. Further, since no details of the registration method are given, it remains open whether a time saving occurs given that an additional step (e.g. up-sampling) is necessary in order, somehow, to manage images with different resolutions during registration.

39. While it is possible that some methods and systems that fall under the claim wording do actually achieve the alleged technical effects, an effect that is not credibly obtained throughout the entire range covered by the claims cannot be relied upon when defining the objective technical problem (Case Law of the Boards of Appeal of the European Patent Office, 9th edition, 2019, I.D.4.3).

40. The Board, therefore, cannot accept the technical effect proposed by the proprietor. For its own part, the Board has not been able to identify any more viable effect.

41. As is well-established in the Boards' jurisprudence, a positive assessment of inventive step can be based only on those elements and aspects of the invention in respect of which a technical effect can be established (Case Law of the Boards of Appeal of the European Patent Office, 9th edition, 2019, I.D.9.1.5). Since here, no technical effect has been established for the "resolution"-feature, it can not be taken into account for the evaluation of inventive step.

42. Hence, the subject-matter of claim 1 lacks an inventive step (Article 56 EPC).

43. Further, the addition made to claim 4

... wherein the radiation therapy plan comprises treatment parameters which have previously been optimized from irradiated tissue contours generated from a planning image ...

is unclear (Article 84 EPC) as to whether "which have been previously optimized from irradiated tissue contours generated from a planning image" implies a step of previously optimizing parameters as part of the claimed method or not.

44. Auxiliary request II' is, therefore, not allowable.

Auxiliary requests II'' and II'''

45. Auxiliary requests II'' and II''' were filed in response to the Board's preliminary opinion and after notification of the summons to oral proceedings. In both cases, claim 1 remains as in auxiliary request II' and the same arguments with regard to inventive step apply. Hence, neither is admitted into the appeal proceedings, since neither is suited to overcoming the objections already raised (Article 13(2) RPBA 2020, under which the criteria of Article 13(1) RPBA 2020 may be applied).

Auxiliary request III

46. In auxiliary request III, the same definitions with regard to the resolutions of images appear as in auxiliary request II. As stated above, the formulations "lower" and "higher" resolution, without explicitly referring to what they are "lower" or "higher" than, result in a lack of clarity (Article 84 EPC). Thus, this request is not allowable for the same reasons as for auxiliary request II.

Auxiliary request III'

47. Auxiliary request III' corresponds to auxiliary request II' with the additional feature:

... wherein the treatment image is not used to extract information on radiation attenuation or tissue density.

48. The additional feature is unclear (Article 84 EPC). Firstly, with regard to system claim 1, it is unclear, how the "non-use" - which (if anything) is a method step - could actually restrict the claimed system. Secondly, there is no reference to radiation attenuation or tissue density in the rest of the claim. As pointed out by the opponent in its reply to the proprietor's appeal (section: auxiliary request III', pages 5 to 6), due to its negative limitation, it is left open, whether radiation attenuation and tissue density are normally needed or not for the system to work, and if they are, where they come from. Thus, this request is not allowable.

Auxiliary request III''

49. Auxiliary request III'' was filed in response to the Board's preliminary opinion and after notification of the summons to oral proceedings. According to Rule 13(2) RPBA, such an amendment shall, in principle, not be taken into account unless there are exceptional circumstances, which have been justified with cogent reasons by the party concerned.

50. The proprietor argued that exceptional circumstances were present, since, in the preliminary opinion, the Board addressed the issue of clarity of the negative limitation in auxiliary request III' (see above) for the first time.

51. While it is correct, that the Board addressed this issue for the first time in its preliminary opinion and that the Opposition Division did not deal with this issue, the proprietor was aware of the problem, since the opponent discussed the matter in 2015, in its reply to the proprietor's appeal (section: auxiliary request III', pages 5 to 6). There was ample time for the proprietor, before the summons was notified, to react to the opponent's argumentation. Thus, no exceptional circumstances are at hand, let alone any cogent reasons that justify them.

52. Further, the proprietor has provided no arguments as to why a method step clearly limits the device or as to how it helps with inventive step.

53. Hence, it is not apparent that the amendment, prima facie, overcomes the issues raised by the opponent or by the Board.

54. Auxiliary request III'' is therefore not admitted into the appeal proceedings (Article 13(2) RPBA 2020, under which the criteria of Article 13(1) RPBA 2020 may be applied).

Auxiliary request IV

55. Claims 1 and 4 of auxiliary request IV lack clarity (Article 84 EPC), since the added feature

... wherein the optimization process is omitted, if the registration process indicates stability of the irradiated region since a last treatment session.

includes an unclear reference to "the optimization process" that lacks an antecedent in the claim. As a consequence, this request is not allowable.

Auxiliary request IV'

56. This request was filed in response to the Board's preliminary opinion and after notification of the summons to oral proceedings. The amendment in auxiliary request IV' overcomes the problem with auxiliary request IV by referring to the "re-optimization" process, which the claims do define. Since no other new issues were introduced, the Board exercises its discretion to admit auxiliary request IV' into the appeal proceedings (Article 13(2) RPBA RPBA 2020, under which the criteria of Article 13(1) RPBA 2020 may be applied).

57. However, the added feature "re-optimizing treatment parameters of the radiation therapy plan from the updated contours" does not establish an inventive step, starting from document D1 or from D8, in combination with common general knowledge or with document D2, in particular paragraph [0021] of the latter, which states: ... if the deviations between the new plan and the already approved plan are within a previously defined tolerance range, then a re-evaluation and approval of the plan [...] may be omitted.

58. It would have been obvious for a skilled person, at the time, only to optimise when there is a need for optimisation.

59. Hence, claims 1 and 4 of auxiliary request IV' lack an inventive step (Article 56 EPC).

Conclusion

60. Since none of the requests on file is allowable, the patent must be revoked.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility